Cinctive Capital Management’s GoodRx Holdings GDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-40,000
Closed -$187K 450
2022
Q3
$187K Buy
+40,000
New +$252K 0.01% 415
2022
Q1
Sell
-30,000
Closed -$980K 571
2021
Q4
$980K Buy
+30,000
New +$1.21M 0.04% 413

Other funds holding GDRX

Cinctive Capital Management's GDRX Position: Q1 2026 in Review

Cinctive Capital Management reduced its GoodRx Holdings (GDRX) stake by 93% in Q1 2026, selling an estimated $540K and leaving 16,863 shares worth $33.1K. The position accounts for ﹤0.01% of the portfolio, ranked #351.

Cinctive Capital Management first reported a position in GDRX in Q3 2020 and has held it in 6 quarters since. The position peaked at $5.15M in Q3 2020. 174 funds tracked by Wall St. Rank hold GDRX as of Q1 2026.

  • Cinctive Capital Management held 16,863 shares of GoodRx Holdings worth $33.1K as of Q1 2026.
  • Cinctive Capital Management sold 230,071 GoodRx Holdings shares in Q1 2026, an estimated $540K.
  • GoodRx Holdings made up ﹤0.01% of Cinctive Capital Management's portfolio in Q1 2026, its #351 holding.
  • Cinctive Capital Management first reported a position in GoodRx Holdings in Q3 2020 and has held it in 6 quarters since.
  • Cinctive Capital Management's GoodRx Holdings position peaked at $5.15M in Q3 2020.
  • 174 funds tracked by Wall St. Rank held GoodRx Holdings as of Q1 2026.

Based on Cinctive Capital Management's 13F filing for Q1 2026, filed 15 May 2026.